Decoding FDA Guidance on Decentralized Trials
Decoding FDA Guidance on Decentralized Trials Last month the FDA released its draft guidance on the use of decentralized clinical trials (DCTs) for drug and device development. We spoke with Chris Fourment, MD, Senior Vice President of Clinical Strategy at Iterative Health, who specializes in structuring clinical trial programs, about the new guidance. He …
